Table 4.

Univariate Competing Risk Analysis of Predictors of Wait-list Removal Due to Improvement

Predictor variables	Sub HR (95 % CI)	p
ALD (vs non-ALD)
At 6 months after listing*	0.87 (0.74–1.03)	0.11
At 1 year after listing*	1.22 (1.08–1.38)	< 0.001
At 2 years after listing*	2.39 (1.94–2.95)	< 0.001
Age, yrs (vs 18–34)
35–49	0.46 (0.39–0.55)	< 0.001
50–64	0.34 (0.29–0.41)	< 0.001
65 and older	0.52 (0.42–0.64)	< 0.001
Female Sex	1.38 (1.25–1.53)	< 0.001
Race (vs White)
Black	1.12 (0.96–1.38)	0.12
Other	0.91 (0.79–1.04)	0.20
BMI (vs 20–29)
Less than 20	1.82 (1.44–2.30)	< 0.001
30–34	0.61 (0.53–0.70)	< 0.001
35–39	0.65 (0.53–0.78)	< 0.001
> or = 40	0.62 (0.46–0.82)	0.001
Blood group (vs AB)
A	1.38 (1.01–1.89)	0.04
B	1.46 (1.05–2.05)	0.03
O	1.35 (0.99–1.84)	0.06
Ascites (Absent)
Slight	0.24 (0.22–0.27)	< 0.001
Moderate or more	0.07 (0.05–0.09)	< 0.001
Spontaneous bacterial peritonitis	0.59 (0.45–0.78)	< 0.001
Encephalopathy (vs none)
Grade 1–2	0.22 (0.20–0.25)	< 0.001
Grade 3–4	0.04 (0.03–0.07)	< 0.001
TIPSS	0.89 (0.73–1.08)	0.24
Portal vein thrombosis	0.82 (0.61–1.10)	0.19
Diabetes	0.66 (0.58–0.76)	< 0.001
Prior malignancy	1.10 (0.88–1.37)	0.38
MELD at listing (vs < 15)
15–24	0.54 (0.48–0.61)	< 0.001
25–34	0.53 (0.44–0.64)	< 0.001
≥ 35	0.42 (0.31–0.56)	< 0.001
Region for listing, by grouping of wait-time (vs low)
Moderate	1.01 (0.90–1.15)	0.79
Long	0.84 (0.73–0.96)	0.01
Cohort (vs 2002–2006)
2007–2011	1.98 (1.70–2.29)	< 0.001
2012–2016	2.75 (2.38–3.17)	< 0.001

^*Significant interaction between alcoholic liver disease and time since listing was identified (p < 0.001). Therefore, subhazard ratios are reported at 6 months, 1 year, and 2 years after listing.